Syphilis treatment and HIV infection in a population-based study of persons at high risk for sexually transmitted disease/HIV infection in Lima, Peru

Sexually Transmitted Diseases

Volumn 33, Issue 3, 2006, Pages 151-155

  Long, Corey M ^a,e   Klausner, Jeffrey D ^a   Leon, Segundo ^b   Jones, Franca R ^c   Giron, Maziel ^b   Cuadros, Julio ^b   Pajuelo, Jose ^b   Caceres, Carlos ^b   Coates, Thomas J ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c California   (Peru)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; DOXYCYCLINE; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE; REAGINIC ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PENICILLIN ALLERGY; PERU; REAGIN TEST; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CLINICAL TRIAL; PREVALENCE; UNSAFE SEX;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; FEMALE; HIV INFECTIONS; HUMANS; MALE; PENICILLINS; PERU; PREVALENCE; REAGINS; SEXUALLY TRANSMITTED DISEASES; SYPHILIS; TREATMENT OUTCOME; UNSAFE SEX;

EID: 33645987607     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000204506.06551.5f     Document Type: Article

References (46)

1. Wasserheit J. Epidemiologic synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
2. Cohen MS. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet 1998; 351(suppl III):5-7.
3. Clottey C, Dalabetta G. Sexually transmitted diseases and human immunodeficiency virus, epidemiologic synergy? Infect Dis Clin North Am 1993; 7:95-102.
4. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
5. Schacker T, Ryncarz A, Goddard D, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men. JAMA 1998; 280:61-66.
6. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of STDs on HIV infection in rural Tanzania: Randomized controlled trial. Lancet 1995; 346:530-536.
7. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51:18-25.
8. Clark EG, Danbolt N. The Oslo study of the natural course of untreated syphilis: An epidemiologic investigation based on a re-study of the Boeck-Bruusgaard material. Med Clin North Am 1964; 48:613.
9. Parkes R, Renton A, Meheus A, Laukamm-Josten U. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 2004; 15:73-88.
10. Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29:486-490.
11. Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of Sao Paulo, Sao Paulo, Brazil. Rev Panam Salud Publica 2003; 13:111-116.
12. Cook RL, May S, Harrison LH, et al. High prevalence of sexually transmitted diseases in young women seeking HIV testing in Rio de Janeiro, Brazil. Sex Transm Dis 2004; 31:67-72.
13. de Lima Soares V, de Mesquita AM, Cavalcante FG, et al. Sexually transmitted infections in a female population in rural north-east Brazil: Prevalence, morbidity and risk factors. Trop Med Int Health 2003; 8:595-603.
14. Camejo MI, Mata G, Diaz M. Prevalence of hepatitis B, hepatitis C and syphilis in female sex workers in Venezuela. Rev Saude Publica 2003; 37:339-344.
15. Southwick KL, Blanco S, Santander A, et al. Maternal and congenital syphilis in Bolivia, 1996: Prevalence and risk factors. Bull World Health Organ 2001; 79:33-42.
16. Levine WC, Revollo R, Kaune V, et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: Impact of an HIV prevention project. AIDS 1998; 12:1899-1906.
17. Persaud NE, Klaskala W, Tewari T, Shultz I, Baum M. Drug use and syphilis: Co-factors for HIV transmission among commercial sex workers in Guyana. West Indian Med J 1999; 48:52-56.
18. Zapiola I, Salomone S, Alvarez A, et al. HIV-1, HIV-2, HTLV-I/II and STD among female prostitutes in Buenos Aires, Argentina. Eur J Epidemiol 1996; 12:27-31.
19. Miranda AE, Alves MC, Neto RL, Areal KR, Gerbase AC. Seroprevalence of HIV, hepatitis B virus, and syphilis in women at their first visit to public antenatal clinics in Vitoria, Brazil. Sex Transm Dis 2001; 28:710-713.
20. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis 1998; 4:5-11.
21. Pan Am Health Organization. Country Health Profile 2002: Peru; Washington, DC: Pan Am Health Organization, 2002. Available at: http://www.paho.org/English/DD/AIS/cp_604.htm.
22. Sanchez J, Gotuzzo E, Escamilla J, et al. Gender differences in sexual practices and sexually transmitted infections among adults in Lima, Peru. Am J Public Health 1996; 86:1098-1107.
23. Trujillo L, Munoz D, Gotuzzo E, Yi A, Watts DM. Sexual practices and prevalence of HIV, HTLV-I/II, and Treponema pallidum among clandestine female sex workers in Lima, Peru. Sex Transm Dis 1999; 26:115-118.
24. Tabet S, Sanchez J, Lama J, et al. HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS 2002; 16:1271-1277.
25. Press N, Chavez VM, Ticona E, et al.; Working Group on AIDS in Peru. Screening for sexually transmitted diseases in human immunodeficiency virus-positive patients in Peru reveals an absence of Chlamydia trachomatis and identifies Trichomonas vaginalis in pharyngeal specimens. Clin Infect Dis 2001; 32:808-814.
26. Garcia PJ, Holmes KK. STD trends and patterns of treatment for STD by physicians in private practice in Peru. Sex Transm Infect 2003; 79:403-407.
27. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-1433.
28. Quinn TC, Cannon RO, Glasser D, et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med 1990; 150:1297-1302.
29. Pereira LH, Embil JA, Haase DA, Manley KM. Prevalence of human immunodeficiency virus in the patient population of a sexually transmitted disease clinic. Association with syphilis and gonorrhea. Sex Transm Dis 1992; 19:115-120.
30. Yogeswari L, Chako CW. Persistence of T. pallidum and its significance in penicillin treated late syphilis with persistent seroreactivity. Br J Vener Dis 1971; 47:339-347.
31. Sparling PF. Natural History of Syphilis. In: Holmes KK, et al. Sexually Transmitted Disease. New York: McGraw-Hill Professional Publishing, 1998:473-478.
32. Hook EW III, Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326:106-190.
33. Romanowski B, Sutherland R, Fick GH, et al. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991; 114:1005-1009.
34. Hutchinson CM, Rompalo AM, Reichart CA, et al. Characteristics of patients with syphilis attending Baltimore STD clinics: Multiple, high-risk subgroups and interactions with human immunodeficiency virus infection. Arch Intern Med 1991; 151:511.
35. Telzak EE, Greenberg MS, Harrison J, et al. Syphilis treatment response in HIV-infected individuals. AIDS 1991; 5:591-595.
36. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997; 337:307-314.
37. Yinnon AM, Coury-Doniger P, Polito R, Reichman RC. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996; 156:321-325.
38. Hicks CB, Benson PM, Lupton GP, et al. Seronegative secondary syphilis in a patient with the human immunodeficiency virus (HIV) with Kaposi sarcoma: A diagnostic dilemma. Ann Intern Med 1987; 107:492-495.
39. Tikjob G, Russel M, Peterson CS, et al. Seronegative secondary syphilis in a patient with AIDS: Identification of Treponema pallidum in a biopsy specimen. J Am Acad Dermatol 1991; 24:506-508.
40. Haas JS, Bolan G, Larsen SA, et al. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis 1990; 162:862-866.
41. Johnson PD, Graves SR, Stewart L, et al. Specific syphilis serological tests may become negative in HIV infection. AIDS 1991; 5:419-423.
42. Augenbraun M, Rolfs R, Johnson R, et al. Treponemal specific tests for the serodiagnosis of syphilis. Sex Transm Dis 1998; 25:549-552.
43. Erbelding EJ, Vlahov D, Nelson KE, et al. Syphilis serology in human immunodeficiency virus infection: Evidence for false-negative fluorescent treponemal testing. J Infect Dis 1997; 176:1397-1400.
44. Goh B, Syphilis Guidelines Revision Group. UK national guidelines on the management of early syphilis 2002. Available at: www.mssvd.org.uk.
45. French P, Syphilis Guidelines Revision Group. UK national guidelines for the management of late syphilis 2002. Available at: www.mssvd.org.uk.
46. Goh B, van Voorst Vader P. European guideline for the management of syphilis. Int J STD AIDS 2001; 12(suppl 3):14-26.